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Osteoporosis is a major public health problem in the United States. The purpose of this
study was to determine the level of awareness among postmenopausal females regarding
the methods necessary to prevent osteoporosis. It was also the purpose of this study to
determine the relationship between a female's awareness of osteoporosis prevention and
her bone health.
Subjects included 73 postmenopausal females, age 50 or older, who had not currently
been diagnosed with osteoporosis. Subjects were chosen from women who volunteered
to complete a questionnaire and to have a free screening bone density measurement.
Data was collected at a retirement community and at an osteoporosis awareness fair.
Subjects were asked to complete a questionnaire to determine awareness of osteoporosis
preventive measures, source of information on the disease, and perceived confidence of
their knowledge of how to prevent the disease. Subjects then underwent a screening bone
density measurement to determine their bone health.
Results indicate 77% of the women studied demonstrated an inadequate knowledge of
measures necessary to prevent osteoporosis. While an insignificant relationship, r=. 14,
existed between a woman’s overall awareness of how to prevent the disease and her bone
health, significant differences between certain aspects of an osteoporosis prevention
program and bone health may exist, specifically in the areas of hormone replacement
therapy and exercise. The subjects’ source of information did not appear to have an effect
on their knowledge of preventive measures, but a relationship was observed between
subjects’ perceived confidence of how to prevent osteoporosis and their bone health.
Furthermore, a discrepancy between perceived and actual confidence, as demonstrated by
the questionnaire score, was seen.
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Chapter One
INTRODUCTION
Females over the age of 50 are more likely to develop osteoporosis than
Alzheimer's disease, heart disease, breast cancer, or ovarian cancer (Dowd & Cavalieri,
1999). Osteoporosis increases a woman's risk of fracturing bones. The threat of a hip
fracture is equal to the combined risk of developing ovarian, uterine, and breast cancer
(National Osteoporosis Foundation, 1998). Of women who experience hip fractures,
24% will die within the year following the fracture. The lifetime risk of death for
females, due to osteoporosis, is comparable to that of breast cancer (Merck & Co., 1998).
The National Osteoporosis Foundation estimated that 80% of the 28 million Americans
who have been affected by osteoporosis are females. Of that population, 10 million have
the disease and another 18 million are at risk due to low bone mass.
In a recent study cited by Dowd & Cavalieri (1999), researchers at UCLA
reported that a mere 28% of women surveyed were aware that they were more likely to
develop osteoporosis than other more publicized diseases including heart disease, ovarian
cancer, and breast cancer. Pal (1999) found in a British study of 82 patients with recent
fractures that only 34 of them were aware of the disease and its risks.
Despite these statistics, a Gallup Survey reported that 75% of women between the
ages of 45 and 75 had never spoken to their physician about the disease (National
Osteoporosis Foundation, 1998). Although physicians should be a primary source of
information about osteoporosis, Weiss and Sankaran (1998) reported that 27% of
college women had no primary source of information on the disease, and 39% had no
secondary source.
Osteoporosis, which literally means "porous bone, " is a progressive disease that
begins early in life (McArdle et. al., 1991). Throughout an individual's lifetime, bone is
constantly being remodeled. During remodeling, both bone-formation and bone1
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resorption occur. This takes place in specific areas called bone-remodeling units and
consists of four phases. During the resting phase, inactive osteoblasts line the bone. This
is followed by the resorption phase in which osteoclasts, after being activated, begin
resorption. A resorption pit is left in the bone by the osteoclasts. This pit is filled in with
a matrix synthesized by the osteoblasts. All of this occurs in the third phase known as the
reversal phase. Finally, in the formation phase, mineralization of the unmineralized
matrix takes place completing the remodeling sequence. Bone-resorption, which is
mediated by osteoclasts, takes approximately seven to ten days. Bone-formation, which
is mediated by osteoblasts, takes approximately three months (Allen, 1993). Initially,
through these two processes of bone-resorption and bone-formation, bone density is
increased with bone-formation being greater than bone-resorption. At about the age of
thirty, peak bone density has been reached and bone-formation and bone-resorption
balance out. In women, once estrogen levels decline due to either amenorrhea or
menopause, bone-resorption overtakes bone-formation (Dowd & Cavalieri, 1999). At
this point osteoporosis can begin.
Osteoporosis is characterized by reduced bone mineral density (BMD) and by
brittle bones that break under normal stress or during falls (McArdle et. al., 1991). The
most conunon fractures occur in the spine since vertebrae consist of trabecular bone that
is spongy and more susceptible to loss. These spinal fractures can lead to pain, loss of
height, and a humped back, also known as "dowager's hump" (Merck & Co., 1998).
Frequent fractures also occur at the end of the radius in the wrist, and at the neck of the
femur at the hip joint. Of the 1.5 million fractures that occur annually, 300,000 are hip
fractures with 50% of the patients becoming disabled and 25% requiring long-term
nursing care (Norland Medical Systems, 1998 and Merck & Co., 1998).
Although it is commonly thought of as an older woman’s disease, osteoporosis
can affect young females. Secondary amenorrheic women are also at risk. Members of
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this group may include anorexics and female athletes such as gymnasts, dancers, and
distance runners (American College of Sports Medicine, 1993). All of the
aforementioned individuals suffer from a decrease in estrogen which is necessary for the
uptake and utilization of calcium.
Decreased estrogen is the major cause of osteoporosis (Williams, 1992). Other
contributing factors include a lack of calcium, heredity, lifestyle, decreased physical
activity, certain medical conditions, and certain drugs such as steroids, anticonvulsants,
and thyroid medications. Treatments for osteoporosis and its prevention include calcium
and vitamin D supplements, hormone replacement therapy (HRT) or other medications
used to prevent bone loss, and exercise. New medications shown to increase bone
density are now also being used. In the past, it was disputed whether or not the effects of
osteoporosis could be reversed. Through the use of these new medications, it appears it
is indeed possible.
It is apparent that osteoporosis is a major public health problem. However, in
many cases it is a preventable and treatable disease. Interest in this topic began when the
researcher's mother was diagnosed with osteoporosis, after numerous fractures, about
seven years ago. A search of the available literature on the disease produced extensive
information on osteoporosis and its prevalence. Information was also available on
women's lack of awareness for developing the disease. However, when searching for
information regarding women's awareness of how to prevent osteoporosis, this was not
the case. It appears minimal research has been done in the area of osteoporosis
prevention awareness. Therefore, it is the intent of this study to add to the body of
literature related to prevention awareness.
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Problem Statement
The purpose of this study was to determine the level of awareness among
postmenopausal females regarding the methods necessary to prevent osteoporosis. It was
also the purpose of this study to determine whether a significant relationship existed
between a woman’s awareness of osteoporosis prevention and her bone health.

Significance of Problem
In women over the age of 50, one in every three already has osteoporosis (Merck
& Co., 1998). However, there is an apparent lack of research concerning women's
awareness of how to prevent the disease. If a significant correlation exists between a
woman's lack of awareness regarding the measures necessary to prevent osteoporosis and
her current bone health, it would suggest that education can be used as a preventive
measure. The results of this research could help to further the awareness of osteoporosis
prevention and increase the use of preventive measures by women to ensure good bone
health.

Hypothesis I:
More of the women surveyed will be unaware of the measures necessary to
prevent osteoporosis than less of the women surveyed.

Justification
Osteoporosis is a preventable and treatable disease. Despite this fact, 28 million
Americans are affected by this condition (National Osteoporosis Foundation, 1998). In
addition to uncontrollable risk factors such as genetics, race, frame size, allergies, and
certain medical conditions, a lack of awareness among postmenopausal females
regarding the methods necessary to prevent osteoporosis may be a contributing factor.
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Hypothesis II:
The bone density of women who are not aware of the measures necessary to
prevent osteoporosis will be less than the bone density of women who are aware of
osteoporosis preventive measures.

Justification
In a study conducted by Nieves et. al. on the effect of calcium in addition to
estrogen and calcitonin therapy on bone density, a substantial mean increase of bone
density of the spine, hip, and forearm was seen (Dawson-Hughes, 1998). Furthermore,
the muscular forces required in exercise appear to modify specific bone at the point of
stress. The mechanical stress is converted to electrical energy. The electrical changes
then stimulate activity of osteoblasts which leads to a build up of calcium (McArdle et.
al., 1991). Therefore, if postmenopausal women are following a regimen of osteoporosis
preventive measures including adequate calcium intake, hormone replacement therapy,
and appropriate exercise, bone density should be positively affected.

Limitations
1. Certain risk factors for osteoporosis such as genetics, race, frame size, allergies and
certain medical conditions exist and are not controllable.
2. An individual's awareness of steps necessary for the prevention of osteoporosis does
not ensure her practice of them.
3. Nutrition, exercise, and other lifestyle practices prior to an individual's education on
osteoporosis prevention can affect bone health and are not controllable.
4. Imaging tests using radioactive materials within five days prior to a DEXA scan, a
diagnostic procedure used to assess bone density, will interfere with the accuracy of the
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bone density measurement.
5. The DEXA scan being used will only measure bone density of the distal radius.
6. The results of the study will not be generalized to any population other than
postmenopausal females over the age of 50 who have not currently been diagnosed with
osteoporosis in Virginia and Maryland.

Définition of Terms
1. DEXA scan: Dual-energy x-ray absorptiometry uses a small amount of radiation to
determine the bone density of the spine, hip, or wrist. These scans are more sensitive
than ordinary X-rays and can diagnose bone loss at an earlier stage. Results of the scan
are compared with the average bone mineral density of healthy young adults of the same
sex at their peak bone mass.
2. Osteoblast: A cell of mesodermal origin concerned with the formation of bone.
3. Osteoclast: Giant multinuclear cell formed in bone marrow of growing bones. Found
in depressions (called Howship's lacunae) on the surface of the bone. Concerned with the
absorption and removal of unwanted tissue.
4. Osteoporosis: A disease in which bones become fragile due to an increased porosity of
bone and a reduction in the amount of bone mass leading to fractures. These fractures
can result in loss of height, stooped posture, and a loss of mobility and independence.
5. T-score: Test result of the DEXA scan. Compares bone density of the subject to that
of the mean bone density of healthy young women of the same race who have reached
peak bone mass. If the score is -1.0 or less, the subject may need therapy.
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Chapter Two
REVIEW OF LITERATURE

Prevention awareness
Until the beginning of the 20th century, osteoporosis and its complications were
relatively unknown due to the fact that the average life expectancy of women did not
exceed menopause (Semla, 1999). Since that time much has been learned about the
disease. Organizations such as the National Osteoporosis Foundation, National Institutes
of Health, and the World Health Organization are all advocates for increasing the
awareness and practice of osteoporosis prevention. Despite this push for increased
awareness, 28 million Americans are affected with this disease (Dowd & Cavalieri,
1999). During the next 60 years, the number of cases of osteoporosis is expected to triple
worldwide due to the increase in life expectancy (Lysen & Walker, 1997). Of the money
spent on health care in the U.S., expenditures for rehabilitative care of osteoporosis
related bone fractures are substantial (Kessenich, 1996). In fact, more than 10 billion
dollars are currently spent annually and the figure is expected to exceed 62 billion dollars
by the year 2020 (Lysen & Walker, 1997 and Kessenich, 1996). As the elderly
population increases, so will the number of fractures. The number of hip fractures alone
is predicted to triple between 1990 and 2040 according to Schneider and Guralnik (Lysen
& Walker, 1997). The estimated cost associated with these hip fractures world wide is
expected to reach 131.5 billion dollars by the year 2050 (Doube, 1999). The most costeffective approach to managing this problem is prevention (Allen, 1993).
Currently, many physicians and much of the general public are unaware that
women reach their peak bone mass at approximately the age of 30 (Andrews, 1998). In a
survey of college women concerning their primary source of information on osteoporosis,
22% listed the media, 27% had no primary source, and 39% had no secondary source
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(Weiss & Sankaran, 1998). A British study of 82 patients with recent fractures found that
only 34 of them were aware of the disease and its risks. In only ten of these cases doctors
were listed as the knowledge source. The media and friends or relatives were the source
of information in the rest. It was also reported that these patients received incomplete or
inadequate advice regarding occupational and physiotherapy, and only a few received
specific treatment on how to reduce future fracture risk with hormone replacement
therapy, bisphosphonates, or even calcium and vitamin D (Pal, 1999). This is occurring
in spite of recommendations that the primary role of physicians in dealing with patients at
risk for osteoporosis is to emphasize preventive strategies focusing on maximizing peak
bone mass (Allen, 1993), The National Institutes of Health Consensus Conference on
Optimal Calcium Intake in 1994 recommended that health professionals play a strong
role in educating about bone health and calcium intake. Nevertheless, it has been
reported that the average woman's diet in America contains less than 600 mg/day. The
recommended minimum calcium intake is 1000 mg/day. A public health education
program is necessary to ensure the desired intake of calcium in the American public
according to an expert panel of the National Institutes of Health (Weiss & Sankaran,
1998). It seems apparent that an increase in the awareness of osteoporosis prevention is
necessary. Osteoporosis is a major public health problem, and the answer to managing it
is prevention (Allen, 1993).
Components of an effective preventive strategy are to ensure peak bone mass
during childhood, adolescence, and early adulthood; maintaining acquired bone mass;
and counteracting the age-related process of bone loss that occurs after age 40 to 45
(Kulak & Bilezikian, 1998). Studies have been conducted and programs implemented to
assess and educate adolescent and young adult populations (Lysen & Walker, 1997 and
Weiss & Sankaran, 1998). These studies and programs are vital to avoid a perpetuation
of the devastating effects of this disease. The prevention focus must not stop there,
however. For women, the average lifetime extends 25 to 35 years after menopause thus
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placing many postmenopausal women at risk for osteoporosis and related fractures
(Semla, 1999). Since no cure for osteoporosis exists and a 10% decrease in bone mineral
density is associated with a doubling or tripling in the increase risk of fracture,
optimizing peak bone mass and maintaining skeletal mass throughout adulthood must be
the main focus of prevention (Lysen & Walker, 1997). Prevention counseling should
include recommendations for calcium and vitamin D intake, weight-bearing exercise, and
pharmaceutical interventions of hormonal therapy available for preventing bone loss
(Kessenich, 1996).
Calcium and Vitamin D
Calcium is an important aspect of an overall program to prevent osteoporosis
(National Osteoporosis Foundation, 1998). In fact, an inadequate calcium intake is said
to be the most important nutritional risk factor for the disease (Allen, 1993). The
National Osteoporosis Foundation (1998) recommends 1,200 mg/day for women over the
age of 50. In postmenopausal women, the recommended daily intake for women not
using hormone replacement therapy (HRT) is 1500 mg/day and 1000 mg/day for
postmenopausal women who are using HRT. For best absorption, the dose should be
divided throughout the day and taken with food (Dowd & Cavalieri, 1999). A decrease
in bone loss of middle-aged postmenopausal women, and a decrease in the rate of
vertebral fractures of women who have previously experienced vertebral fractures has
been observed when using supplemental calcium (Dawson-Hughes et. al., 1997). In fact,
calcium supplementation has been shown to reduce the rate of bone loss in
postmenopausal women by approximately 0.8%/year. When compared with untreated
women, this is a decrease of 40%. The greatest preservation of bone mass by calcium
alone has been observed in the hip and forearm (Nieves et. al., 1998).
Due to a suspected decrease in the ability of the kidneys to produce l,25(OH)2D3
in the elderly and postmenopausal women, absorption of calcium by the intestine is
hindered. Because of this, bone becomes a greater source of the calcium necessary to
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maintain extracellular fluid calcium levels. Only large amounts of calcium, 1500 to 2500
mg/day, can overcome this (Arnaud & Sanchez, 1990). Unfortunately, the intake of
excessive amounts of calcium has side effects such as abnormal heart contractions, the
development of kidney stones, constipation, and the possibility of interfering with the
absorption of iron and zinc (Williams, 1992). These side effects are one reason calcium
alone should not be used to prevent osteoporosis. Fortunately, synergistic effects
between calcium and physical activity, and between calcium and estrogen have been
observed resulting in increased bone mass.
Lysen and Walker (1997) cited that research exists supporting the existence of a
positive increase in bone mass when calcium intake and physical activity are at
intermediate or higher levels. In regards to the use of calcium and estrogen, Nieves et. al.
(1998) cite a study in which doses of estrogen thought to be too low to preserve bone
mass (0.3 mg) were found to be as effective as the optimal estrogen dose (0.625 mg)
when taken with 1700 mg of calcium. This calcium dose is high, however, and the
resulting side effects of too much calcium could occur. The same authors also cite a
study in Hong Kong that found similar results when calcium was taken in addition to
estrogen. A significant increase in bone mass of the femoral neck was observed when
compared with the use of estrogen alone. In summation, estrogen and adequate calcium
intake seem to be of greater benefit together than the sum of each effect alone.
Specifically, an increase in bone mass of the femoral neck of 2.4%/year; an increase of
2.1 %/year of the forearm; and an increase of 3.3%/year in the lumbar spine.
Calcium was also shown to have a greater effect when taken with vitamin D.
Vitamin D aids in the absorption of calcium by allowing calcium to leave the intestine
and enter the bloodstream. A dose of 400 to 800 lU/day is recommended, and massive
doses are cautioned against (National Osteoporosis Foundation, 1998). In a three year
study of men and women over the age of 65 using dietary supplementation of vitamin D
and calcium, a moderate reduction in bone loss was observed at the femoral neck, spine
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and total body as well as a decrease in the risk of nonvertebral fractures. Due to the
small number of subjects, caution should be exercised when interpreting the nonvertebral
fracture risk. However, similar results were observed in a French study (Dawson-Hughes
et. al., 1997).
Additional research has shown that vitamin D alone can be useful in reducing
bone loss. A reduction in bone loss of the femoral neck in postmenopausal women was
reported, but not in the rate of hip fracture of elderly Dutch men and women when given
vitamin D supplementation. A decrease in the rate of arm fractures among elderly
Finnish subjects was observed following annual intramuscular injections of vitamin D
(Dawson-Hughes et. al., 1997).
Exercise
In addition to an adequate intake of calcium and vitamin D, exercise should be
part of an osteoporosis prevention program. An exercise prescription of 30 to 60 minutes
of a weight-bearing activity three to four times/week is advised (Allen, 1993). Weight
bearing activities are ones in which the individual works against gravity such as walking,
stair climbing, aerobic dance, racquet sports, and jogging (National Osteoporosis
Foundation, 1998). While not a weight bearing activity, swimming has also been shown
to increase bone mass (Dowd & Cavalieri, 1999). When compared with a nonexercising
control group, a group of male swimmers was found to have a small increase in radial
and vertebral bone mineral density (Niewoehner, 1993).
W olffs law states that "stress or mechanical loading applied to the bone via
muscle and tendons has a direct effect on bone formation and remodeling" (Layne &
Nelson, 1998). Increased bone strength gained by exercise can prevent fractures.
Additional benefits to an exercise program in the prevention of osteoporosis are an
increase in muscle strength, flexibility, and coordination (Chesnut, 1993). However, the
National Osteoporosis Foundation (1998) states that benefits of exercise only last as long
as a program is maintained.
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The types of exercises that should be included in a program to prevent
osteoporosis are aerobic in nature. Layne and Nelson (1998) report that over the last ten
years numerous studies, both cross-sectional and longitudinal in nature, have also shown
a positive and direct relationship between the effects of resistance training and bone
density. In contrast, few studies have shown resistance training to have little or no effect
on bone density.
Results of these manifold studies supporting the existence of a positive and direct
relationship between bone density and resistance training include the following
information. While both aerobic and resistance training provide a weight-bearing
stimulus to bone, it appears resistance training may have a more profound site specific
effect. Male weight lifters have been found to have a greater BMD than nonathletes.
Female athletes observed in cross-sectional studies also showed that resistance training is
positively associated with bone density (Layne & Nelson, 1998).
Furthermore, the effects of resistance training and bone density have been
reported in older populations. Postmenopausal women that were previously sedentary
exhibited a positive effect on multiple risk factors for osteoporotic fracture after
participation in resistance training (Evans, 1999). The common aspect of all these studies
is a moderate- to high-intensity resistance training protocol and significant gains in
strength (Layne & Nelson, 1998).
The benefits of resistance training for postmenopausal women go beyond a
positive effect on bone density. A decrease in the risk for multiple risk factors for
osteoporosis can be achieved through this activity. Muscle strength, balance, agility, and
resilience are all critical in maintaining functional independence and resisting falls.
These effects of resistance training can make a difference in a person's ability to climb
stairs, rise from a chair, carry groceries, etc. (Layne & Nelson, 1998).
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Hormone replacement therapy
The addition of hormone replacement therapy (HRT), or estrogen, to an
osteoporosis prevention program of adequate calcium and vitamin D intake plus weight
bearing exercise makes it complete, HRT has been called the "gold standard" of therapy
for the treatment of osteoporosis (Kulak & Bilezikian, 1998). After menopause, it is
recommended as an antiresorptive agent to prevent bone loss (Galsworthy & Wilson,
1996 and Dowd & Cavalieri, 1999). In postmenopausal women, HRT remains the most
effective measure for the prevention of osteoporosis (Andrews, 1998). In fact, the loss of
bone seems to be prevented even when HRT is started 10 to 15 years after menopause
(Galsworthy & Wilson, 1996). Estrogen increases the gastrointestinal absorption of
calcium, thus sparing the bones as a calcium source and maintaining BMD when calcium
intake is adequate (Barrett-Connor, 1992 and Dowd & Cavalieri, 1999). This adequate
calcium intake is critical since it has been suggested that a greater calcium supply may be
needed to fill the remodeling spaces of bone with new bone (Nieves et. al., 1998).
Several studies have shown HRT is also effective in increasing bone mass and preventing
osteoporotic fractures (Kessenich, 1996 and Andrews, 1998). In women who received
oral estrogens for three years, a decrease in hip fracture rates of 50% was observed, and a
significant decrease in crush fractures or wedge deformities of the spine was noted
(Barrett-Connor, 1992).
Additional benefits of HRT include a reduction in menopausal symptoms, a
decrease in the risk of colon cancer of about 50%, a decrease in the rate of death from
coronary artery disease of about 30-50%, a possible decrease in the incidence of
Alzheimer’s disease, a decrease in tooth loss, the improvement of short-term verbal
memory, and the prevention of collagen loss from the skin (Andrews, 1998).
Grodstein et. al. (1997) declared that current hormone users had a lower risk of
death than subjects who had never taken hormones. However, this survival benefit was
lower for women at a decreased risk for coronary disease. The inverse relationship to
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coronary disease can be explained by the benefit of HRT in reducing the risk of coronary
disease. This apparent benefit also decreased with long-term use of 10 years or more due
to an increase in the risk of mortality from breast cancer. However, the researchers cited
a hypothesis by Sturgeon et. al. that women who use hormones discontinue their use of
them once they develop symptoms of a fatal disease. This would then classify them as
recent or past hormone users leaving only healthy women classified as current hormone
users. If this is true, the results of this study may not be valid.
The researchers also cite a study by Posthuma et. al. that reported a lower risk of
some types of cancer among hormone users. It was suggested, however, that this lowered
risk was not a result of the hormone therapy itself but rather a reflection of only healthy
postmenopausal women being chosen for hormone therapy. While there may be validity
to this suggestion, the recent studies that have found a significant reduction in the
prevalence of colon cancer with hormone use cannot be ignored (Grodstein et. al., 1997).
Unfortunately, postmenopausal HRT has side effects and hazards associated with
it as well as benefits. The National Osteoporosis Foundation (1998) reports side effects
such as breast tenderness, weight gain, mood swings, and menstrual-like bleeding have
been observed. The re-establishment of this vaginal bleeding will decrease and
eventually stop, however (Andrews, 1998).
In the Nurses’ Health Study, women taking hormones appeared to be at a greater
risk for developing breast cancer. However, the risk for developing this cancer appeared
to be greater than the risk of dying from it (Grodstein et. al., 1997). Andrews (1998)
reviewed 55 studies in this area and concluded that the results of whether or not HRT
increases a woman’s risk for breast cancer have been inconsistent.
An increase in the risk of developing uterine cancer has also been associated with
HRT. However, this risk can be offset by the concurrent administration of progestin with
estrogen in postmenopausal women with a uterus (National Osteoporosis Foundation,
1998; Allen, 1993; and Andrews, 1998). This addition of progestin does not appear to
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affect the efficacy of estrogen (Kessenich, 1996).
Conclusions
Osteoporosis is a major public health problem that affects the quality of life,
especially for postmenopausal women. A continued effort to increase the awareness of
both health care professionals and the general public about methods to prevent this
disease is certainly warranted. A prevention program consisting of adequate calcium and
vitamin D intake, weight-bearing exercise, and hormone replacement therapy has been
shown to bring about positive results in maintaining and possibly increasing bone mass.
Each of these therapeutic aspects appear to increase bone health separately, but the
greatest effect has been observed when they are used together.
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Chapter Three
METHODOLOGY

Subjects
Seventy-three females were chosen from volunteers registered for a screening
bone density measurement through Bone Health Diagnostics of Fairfax, Virginia. Bone
Health Diagnostics is a private practice specializing in rheumatology. This research was
conducted with the cooperation of Bone Health Diagnostics who provided baseline data
for the study.
Flyers were distributed at numerous local pharmacies and retirement homes
informing women of the opportunity to receive a screening bone density measurement.
Media coverage announcing an osteoporosis awareness fair with free bone density
screening at a local shopping mall was also provided. Screening took place on site on
the specific dates listed on the flyers and media announcements. Interested persons were
asked to make an appointment in advance. From females who signed up, subjects were
chosen based on meeting the following criteria: 1) at least 50 years of age, 2)
postmenopausal, and 3) not currently diagnosed with osteoporosis. Individuals who did
not meet the above criteria were still provided the screening bone density measurement,
but were not included in the study. Subjects were required to complete and sign a
consent form (See Appendix C) for Bone Health Diagnostics for the screening bone
density measurement as part of Bone Health Diagnostic's protocol. An informed consent
form was also completed for the study itself (See Appendix B). All subjects were
assigned a numerical code and confidentiality was maintained by referring to subjects
using code only.

16
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Questionnaire completion
Prior to the screening bone density measurement, subjects were asked to complete
a questionnaire (See Appendix D) concerning knowledge of measures necessary for
osteoporosis prevention. The questionnaire consisted of eight questions (numbers five to
twelve on the questionnaire), seven of which were multiple choice and one that was true
or false. The questions focused on the major components of an osteoporosis prevention
program: calcium and vitamin D intake, exercise, and hormone replacement therapy used
for the preservation of bone mineral density. A score between zero and eight was
assigned corresponding to the number of correct responses given on the questionnaire.
Subjects were also asked to identify their primary information source on osteoporosis,
and whether or not they were confident of their knowledge of the measures necessary to
prevent osteoporosis. In addition, the questionnaire served as a screening tool and asked
the subject's age, if they were postmenopausal, whether or not they had currently been
diagnosed with osteoporosis, and if they had undergone any of several diagnostic
procedures in the last five days that could interfere with the screening bone density
measurement. The questionnaire scores of females, meeting eligibility criteria, were
used in the study. Subjects with questionnaire scores of zero to five were classified as
demonstrating an "inadequate knowledge of osteoporosis preventive measures," while
subjects with questionnaire scores of six to eight were considered to possess an "adequate
knowledge of osteoporosis preventive measures." These parameters were determined
based on what is considered a reasonable score by academic standards. Five or less
correct out of eight is the equivalent of 63% or less.
Screening bone density measurement
Upon completion of the questionnaire, each subject underwent a screening bone
density measurement. The test was performed on site by a nurse practitioner employed
by Bone Health Diagnostics of Fairfax, Virginia. The Norland pDEXA Bone
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Densiometer was used. Due to its small size, the machine is portable. A scan was made
of the distal radius in the wrist. The subject was asked to remove any items that may
interfere with the test such as a bracelet or watch. According to Kanis and the World
Health Organization Study Group, all tests regardless of whether they measure bone
density of the wrist, hip, or spine provide important information to assess fracture risk
(Norland Medical Systems, 1998). The subject then sat and placed her dominant arm
under the Norland pDEXA Bone Densiometer. The subject was asked to remain still
during the two or three minute duration of the test. Adjustable straps were also used to
prevent movement. A printout of the subject's T-score was produced at the end of the
test. The T-score compared bone density of the subject to that of the mean bone density
of healthy young women of the same race who have reached peak bone mass. Both the
size and direction of the T-score are indications of bone health. In other words, positive
scores are better than negative scores. A T-score of -1.0 or less suggests the subject may
need therapy. The T-scores of females, meeting eligibility criteria, served as the baseline
data for this study.
Research Design and Statistical Procedures
Awareness of osteoporosis preventive measures as determined through
completion of the questionnaire was rated on a scale of zero to eight. A score of five out
of eight (63%) or less was considered to demonstrate an inadequate awareness of the
measures necessary to prevent osteoporosis. T-scores from the bone density screen were
standardized scores ranging from a -3.99 to +3.99. A score of -1.0 or less was considered
to indicate possible poor bone health. The World Health Organization provides the
interpretation for T-scores in Table 1.
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Table 1. World Health Organization T-score interpretation
T-Score

Interpretation

> -l

Normal bone density

-2.5 to -1

Osteopenia - moderate fracture risk

<-2.5

Osteoporosis - high fracture risk
The frequency of each score was determined and a frequency distribution was

constructed. Percentages were then calculated for the questionnaire scores, the perceived
confidence responses, and osteoporosis information source responses.
A Pearson Product Moment Correlation, or Pearson r, and a scatter plot were used
to determine the correlation between the overall questionnaire score and bone density Tscores. A Pearson r is used to determine the correlation between two sets of data. The
correlation is given using the variable r which will range in value from -1.0 to 1.0. The
closer r is to 1.0 in either the direction, the stronger the relationship. A scatter plot is a
visual representation of where data falls. High concentrations in the shape of a diagonal
parabola to either the left or right indicate a strong correlation. Descriptive statistics of
mean and standard deviation were also used since correlation by itself is an incomplete
description of two-variable data (Moore, 2000).
T-tests were then conducted for each individual question to establish if a
significant difference existed between the average bone densities of individuals who
answered the question correctly, and those who answered the question incorrectly. The
function of a t-test is to establish the existence of a difference when dealing with the
means, or averages, of two sets of data. A t-test was also used to determine the difference
between the subjects' perceived and actual awareness of osteoporosis preventive
measures.
When determining if a significant difference existed between the subjects' source
of information and the mean questionnaire score, a one way analysis of variance, or
ANOVA, was used. An ANOVA is used when dealing with multiple means as was the
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case with data concerning the subjects' main source of information on osteoporosis.
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C hapter Four
RESULTS

Data collection
Upon completion of the study, 73 subjects met eligibility criteria and were
included in the research project. Data was collected at a retirement community as part of
a health fair, and at a shopping mall as part of an osteoporosis awareness fair. After the
first set of data was collected, an additional response choice of "I don't know" was added
to the questionnaire (See Appendix D). This was done after a number of subjects stated
that they couldn't answer a question because they didn't know the answer. All subjects
were female, at least 50 years of age, postmenopausal, and had not been diagnosed with
osteoporosis as of the collection date. Copies of individual bone density screens with Tscores were then obtained from Bone Health Diagnostics, and completed questionnaires
were evaluated and scored.
Statistical analysis
The frequency of each score was determined and can be found in Table 2.
Overall, 56 of the 73 subjects surveyed received scores of five or less, and thus were
classified as possessing an inadequate awareness of osteoporosis preventive measures.
Classification was based on scores of less than 65% generally viewed as failing by
academic standards. This is equivalent to almost 77%, and supports Hypothesis I which
states, "More of the women surveyed will be unaware of the measures necessary to
prevent osteoporosis than less of the women surveyed. "
Further statistical analysis revealed a mean score of 4.3 and a standard deviation
of 1.71. The mean of 4.30 translates to a score of 54%. This definitely qualifies as
demonstrating an inadequate knowledge of osteoporosis preventive measures for the
group as a whole and provides further support for Hypothesis I.
21
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Table 2. Questionnaire score frequency distribution

Questionnaire
Score
0

Frequency

Percent

3

4.1

Cumulative
Percent
4.1

1

3

4.1

8.2

2

5

6.8

15.1

3

7

9.6

34.7

4

17

23.3

47.9

5

21

28.8

76.7

6

12

16.4

93.2

7

5

6.8

100.0

8

0

0

100.0

Total

73

100.0

100.0

To test Hypothesis II, the Pearson r was used to determine the correlation
between the subject's questionnaire score and her bone density T-score. A correlation, or
r =.14, was calculated which indicated virtually no relationship since it was not close to
1.0 in either direction (See Figure 1). Furthermore, no real concentration or direction was
observed in the scatter plot that was constructed and concurred with this finding (See
Figure 2).
Figure 1. Results of Pearson r
Correlations
QSCORE

DENSITY

Pearson Correlation
Big. (2-tailed)
N
Pearson Correlation
Big. (2-tailed)
N

QSCORE
1.000
.

73
.141
.235
73

DENSITY
.141
.235
73
1.000
73
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These statistics do not support Hypothesis II which states, "The bone density of
women unaware of the measures necessary to prevent osteoporosis will be less than the
bone density of women who are aware of osteoporosis preventive measures."
Figure 2. Scatter plot results of Pearson r showing relationship
between questionnaire score and bone density T-score

LU
■2

0

2

4

6

8

QSCORE

T-tests were then conducted for each separate question to see if a significant
difference existed between the average bone densities of individuals who answered the
question correctly, and those who answered the question incorrectly (See Table 3). For
questions five and six that dealt with calcium intake, the t-tests revealed no significant
difference. Question seven asked about Vitamin D intake. Surprisingly, subjects who
answered the question incorrectly, had a higher mean bone density than those who
answered it correctly. No significant difference was found to exist between Question
eight, which dealt with the function of Vitamin D, and the mean bone density of the
subjects studied. The t-test performed for Question nine did reveal a difference with the
mean bone density of subjects who answered the question incorrectly being -1.43, and
-0.83 for those who answered it correctly. However, p=.08 which is rather large. This
question was concerned with hormone replacement therapy and its effectiveness in
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preventing osteoporosis. Question ten also dealt with hormone replacement therapy, and
no significant difference was found to exist using the t-test. Questions eleven and twelve
were related to exercise and its role in preventing osteoporosis. Subjects who answered
Question 11 incorrectly had a mean bone density score of -1.41 while subjects who
answered it correctly had a mean bone density score of -0.74. This appears to show some
difference between knowledge of exercise in prevention of osteoporosis and bone health,
but p=.09 and is somewhat large. For the second question dealing with exercise, p=.04
was calculated which is much smaller. A difference was observed here with the mean
bone density score of individuals who answered the question incorrectly being -1.83 as
compared to -1.05 for those who answered correctly.
Table 3. Summary of t-test results for individual questions
Mean T-score
of subjects
who answered
incorrectly
-1.22

Mean T-score
of subjects
who answered
correctly
-1.20

p value

5

Osteoporosis
prevention
program
component
Calcium intake

6

Calcium intake

-1.11

-1.27

.61

7

-.98

-1.86

.03

-1.34

-1.14

.52

-1.43

-.84

.08

-1.41

-1.16

.45

11

Vitamin D
intake
Vitamin D
intake
Hormone
replacement
therapy
Hormone
replacement
therapy
Exercise

-1.41

-.74

.09

12

Exercise

-1.83

-1.05

.04

Question #

8
9

10

.95

Because the main objective of this project was to determine awareness of
osteoporosis prevention measures, two areas of interest related to awareness were
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Studied. The first was the subjects' source of information on the disease, and the second
was if the subjects were confident of their knowledge of how to prevent osteoporosis.
In regards to their primary source of information on osteoporosis, 12% reported a
family member or friend, 52% chose the media, 30% felt their physician was their main
source, three questionnaires contained no response to the question, and one chose all
three of the above (See Table 4).
Table 4. Subject self-reported information source on osteoporosis
Information
source
Family member/
friend
The media

Number of
subjects reporting
9

Percent of total
subjects
12%

38

52%

Your physician

22

30%

Your pharmacist

0

0%

No response

3

4%

Multiple sources

1

1%

A one way analysis of variance, or ANOVA, was conducted to see if there was a
connection between the subjects’ source of information on osteoporosis and the mean
questionnaire scores. No significant difference was observed between the subjects'
source of information and the questionnaire score using the one way ANOVA (p=.14).
However, mean questionnaire scores of the subjects, regardless of the reported
information source, all demonstrate an inadequate knowledge of osteoporosis preventive
measures. Subjects that did not choose an information source, or multiple sources were
not included in the statistical analysis (See Table 5).
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Table 5: Source of information and corresponding mean questionnaire score
Number of
subjects reporting
9
38

Source of
information
Family
member/friend
The media

4.7

22

Your physician

4.4

Mean questionnaire score
3.6

When the subjects were asked whether or not they were confident of their
knowledge of the steps to take to prevent osteoporosis, 53% answered yes, 45%
responded no, and one questionnaire contained no response to the question. In addition, a
t-test was conducted to see if a difference existed between the subjects' self-reported
confidence, or lack of confidence, in their knowledge of how to prevent osteoporosis and
their mean questionnaire scores. A p=.03 was calculated showing a difference between
the subjects' confidence level in their knowledge of how to prevent osteoporosis and the
mean questionnaire scores. The mean questionnaire score of subjects who reported
feeling confident was 4.7 versus 3.9 for those who did not feel confident. While both
mean scores still qualify as inadequate knowledge of osteoporosis preventive measures,
subjects that were confident of their knowledge on the subject did obtain higher scores on
the questionnaire (See Table 6).
Table 6. Perceived confidence vs. actual confidence of subjects concerning
knowledge of how to prevent osteoporosis
Number of subjects
reporting

Mean questionnaire score

39

Confident in knowledge
of how to prevent
osteoporosis?
Yes

33

No

3.9

4.7

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

27

Summary o f results
Seventy-seven percent of the women studied demonstrated an inadequate
knowledge of measures necessary to prevent osteoporosis. While an insignificant
relationship was found to exist between a woman’s overall awareness of how to prevent
the disease and her bone health (r=.14), significant differences between certain aspects of
an osteoporosis prevention program and bone health existed, specifically in the areas of
hormone replacement therapy and exercise.
Concerning sources of information on osteoporosis, 30% of the subjects studied
reported their physicians and 52% felt the media was their main source. Regardless, no
significant difference was found to exist between the source of the subjects' information
and their bone health.
A significant difference was found, however, between the subjects' perceived
confidence of how to prevent osteoporosis and actual confidence as demonstrated by her
questionnaire score.
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Chapter Five
DISCUSSION

Relevance o f findings
More and more, osteoporosis, a disease affecting millions of women and men, is
regarded not only as a treatable, but also a preventable disease. This research supports
the idea that a lack of awareness concerning certain preventive measures, specifically in
the areas of hormone replacement therapy and exercise, may contribute to this.
Previous studies have shown that women were unaware of their risk of developing
osteoporosis (Dowd & Cavalieri, 1999 and Pal, 1999). This study has contributed to the
body of knowledge concerning osteoporosis by establishing that women were also
unaware of what they could do to prevent it. While adolescents and young adults are
being assessed and educated concerning their practice and knowledge of osteoporosis
preventive measures, it is possible that older, postmenopausal females are being ignored
(Lysen & Walker, 1997 and Weiss & Sankaran, 1998). This is unfortunate considering
that current research has shown positive effects both on reducing bone loss and
decreasing fractures in postmenopausal individuals when following different aspects of
an osteoporosis prevention program (Dawson-Hughes et. al., 1997). Clearly, this
population of postmenopausal females needs to be included when educating the public on
preventive measures.
In regards to educating this target group, it is beneficial to consider what the
participants report as their main source of information on osteoporosis. Fifty-two percent
of the women in this study listed the media as their primary source. This is much larger
than the 22% of college females that reported the media as their primary source of
information in a previous study (Weiss & Sankaran, 1998). In order to promote greater
awareness using the media, both the quality and the quantity of information disseminated
28
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to postmenopausal women needs to be increased.
The media could also prove to be a useful tool in encouraging women to speak to
their physicians about the disease. Physicians should be prepared to deal with these
questions, and should include counseling on how to prevent osteoporosis, halt, or slow
bone loss as part of routine check-ups of women even after they have reached
menopause. Only 30% of the women who completed the survey listed their physician as
their primary source of information on the disease. This coincides with an earlier Gallup
Survey in which only 25% of women in approximately the same age group had spoken
to their physician about osteoporosis (National Osteoporosis Foundation, 1998), but is
larger than the 12% reported in a British study of recent fracture patients (Pal, 1999).
This is the case in spite of the recommendation by experts in the field that physicians and
health care professionals play a strong role in educating individuals about the disease
(Allen, 1993 and Weiss et. al., 1998)
Regardless of their information source, 53% of the women in this study felt
confident of their knowledge of how to prevent osteoporosis. While this is not a
devastatingly low number, it does not coincide with questionnaire scores. None of the
women received a perfect score, and only 23 % received a score that was considered to
represent an adequate awareness of how to prevent the disease (See Table 1). This
compounds the problem. Not only does it appear that many women actually do not know
what they can do to prevent the disease, some of them are under the misconception that
they do know. A discrepancy exists between perceived and actual awareness. A p=.03
was calculated from a t-test and shows a significant difference between the mean
questionnaire scores of women who are confident of their knowledge of how to prevent
osteoporosis, and those who are not.
This lack of awareness, however, is not the only factor contributing to bone
health. Genetics, race, frame size, allergies, and certain medical conditions are all
uncontrollable risk factors for osteoporosis. Therefore, any one of these, or a
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combination of them, could result in a low bone density regardless of the subject’s
knowledge of how to prevent osteoporosis. This could be responsible in part for the lack
of correlation between a subject’s awareness as determined by the questionnaire score and
her bone density. Also contributing to this could be the subject’s lifestyle. For example,
a woman may have a diet rich in calcium and Vitamin D, perform weight-bearing
exercise, and be on prescription hormone replacement therapy for reasons other than
osteoporosis prevention. In fact, she may do this without even being aware that these are
all part of an osteoporosis prevention program. This too could contribute to the lack of
correlation observed in this study.
However, when individual questions were analyzed for a connection to bone
health, some differences in the areas of hormone replacement and exercise were found.
Hormone replacement therapy is regarded as the most effective measure for the
prevention of osteoporosis in postmenopausal women (Andrews, 1998). Nevertheless,
only 27 of the 73 women surveyed, or 37%, were aware of this based on their answer to
question nine (See Appendix D). Also, the mean bone density of the 63% who answered
the question incorrectly was -1.43 as compared to -0.84 for those who answered it
correctly. It is suggested that a bone density T-score of -1.0 or less requires therapy. A
p=.08 was associated with this statistic which is somewhat large and therefore warrants
caution when interpreting, however.
In the area of exercise, subjects were asked to choose which form was least likely
to maintain bone mass (See Appendix D) in order to determine knowledge of what
constitutes weight-bearing exercise. Only 22 of the 73 subjects, or 30%, answered the
question correctly. The mean bone density of these individuals was -0.736 as compared
to -1.41 for those who answered the question incorrectly. A p=.09 was calculated for this
statistic and is once again somewhat large. This needs to be taken into consideration
when determining significance of the difference. Subjects were also asked why exercise
was helpful in the prevention of osteoporosis (See Appendix D). While more women
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answered correctly than incorrectly, the average bone density of women who answered
incorrectly was -1.83 as compared to -1.05 for those who answered correctly with p=.04.
This value is smaller than the ones seen previously, and certainly is indicative of a more
significant difference.
In summary, while a significant correlation between the overall questionnaire
score and bone density was not observed, differences were observed between questions
that dealt with specific components of an osteoporosis prevention program and the bone
density score. These areas of hormone replacement therapy and exercise require further
study.
Implications fo r future research
Seventy-seven percent of the women surveyed demonstrated an inadequate
knowledge of measures necessary to prevent osteoporosis. This is similar to the 72% of
women previously found to be unaware of their risk of getting this disease (Dowd &
Cavalieri, 1999). This noted relationship between these two findings could be
investigated through further research.
In addition, while no significant correlation was found to exist between a subject's
awareness of how to prevent osteoporosis and her bone health, refining the questionnaire
should provide more information. Including an answer choice of "I don't know " in all
questionnaires may help to eliminate correct answers that were obtained by guessing.
Furthermore, while the pattern of the scatter plot does not suggest that a larger sample
would provide a different result, increasing the sample size is a possibility. Cost seems to
be a determining factor in a subject's willingness to participate in the bone density
screening measurement, and hence in determining sample size. Both instances of data
collection included free screenings for this study. Additional screenings would have
required a charge, and a lack o f interest was observed when attempting to schedule these.
However, Medicare has recently approved coverage of bone density screenings. Since
many of the women being studied may be covered by Medicare, this could help alleviate
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the situation. Also, a variety of pharmaceutical companies now have medications
approved for treating osteoporosis and may be interested in subsidizing the cost of
research in this area in order to promote awareness of their product. By eliminating the
cost of the procedure to the subject, sample size could be increased.
These future studies could also focus on the hormone replacement and exercise
components of an osteoporosis prevention program. Differences between a knowledge of
these and the subjects’ bone health were observed in this study, and continued research
could help to determine the significance of these differences.
Continued and increased promotion of how to prevent osteoporosis by national
and international groups such as the National Osteoporosis Foundation, the National
Institutes of Health, and the World Health Organization will continue. The result of this
should be an increase in awareness of what can be done to prevent osteoporosis. Future
studies similar to this one could help assess to what extent awareness increases as these
organizations continue their work. Since a majority of women chose the media as their
main source of information, it is likely an increase would be seen.
Studying physicians' knowledge of osteoporosis preventive measures, and what
amount of counseling they are giving patients in the area of osteoporosis prevention is
also an area to research. This study supported previous findings in which physicians are
not sited as primary sources of information in spite of recommendations to the contrary
by researchers in this field. The education of health care providers may also be warranted
to increase knowledge in this area.
This education of the public through the media and health care fxroviders may also
decrease the discrepancy between the perceived and actual awareness of osteoporosis
measures observed in this study. Future studies similar to this one could help to assess
not only to what extent awareness increases, but also if the discrepancy between
perceived and actual awareness decreases.

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

33

As suggested previously, educating women of all ages concerning the components
of an osteoporosis prevention program is certainly warranted. Taking it a step further and
studying to what extent awareness relates to actual practice would also be a valid
direction in which to take this research.

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

34

APPENDIX A

O steoporosis
Are You at Risk?

O steoporosis Screening w ill be available on
W ednesday, May 5***, 1999 - 10:00am -4:00pm at
The Medicine Shoppe* 6960 Braddock Rd. - Annandale, Va
*Advance appointm ents are required.*
Sign up at th e front desk or Call (7 0 3 ) 941-1410
Screening P DEXA scans typically cost about $100 In a physician’s office/hospital.

This screening is being offered at a special rate of $35.
Sign-up T o d ay t o H a v e a Screening B one D en sity M easurem ent.
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O steoporosis
Are you at risk?
Osteoporosis is not just a concern for senior citizens.
Did you know that at the ripe **old’*age of about 30 your bone balance shifts to greater bone loss than
formation? “After 25 to 30 years of age the bones have reached their peak bone mass” reports Dr. Leila
Zackrison a Rheumatologist and Osteqporosis specialist in Fairfax, Virginia.
From that point on bmies are suscqnible to a degoieration process and the early st%es of Osteoporosis can
begin. Osteoporosis is a condition in which bone mass (also known as bone strength or bone density)
decreases to the point where loss of height and fractures occur.

WHO IS AT RISK?
Caucasian, Asian and Hispanic females are at the highest risk for Osteoporosis. But, many people do not
realize that 20% of individuals diagnosed with Osteoporosis are men! Other risk factors include poor
nutritional habits; lack o f exercise, a ftunily history o f Osteoporosis, being small framed as well as eating
disorders (Anorexia nervosa). Certain illnesses and medications such as steroids, thyroid medications and
anticonvulsants can also increase an individual’s risk for Osteoporosis.
Most importantly, a person’s bone density is not visible or apparent. Bone loss is silent and occurs without
symptoms. To identify individuals at risk for Osteoporosis, it is necessary to have a BONE DENSITY
TEST. The test is quick and painless.

PREVENTION:
Osteoporosis is a preventable disease if identified in its early st%es. Many physicians agree that the key to
prevention is to have a screening bone density measurement after the age of 30. This test is classified under
preventative medicine in most cases.
Most experts agree that it is very unlikely that an individual will continue to build bone density after the age
of 30. However, maintaining healthy bone density levels are best achieved through regular weight bearing
exercise (i.e. brisk walking, jogging, etc.), proper nutrition, absorbable calcium supplementation, and certain
approved medications if indicated.

RISK APPRAISAL - Questionnaire
1.
2.
3.
4.
5.
6.
7.
8.
9.

(Check Yes or No)

Are you female?
Are you Caucasian, Asian or HQspanic?
Do you have a small frame?
Do you eat less than 3 servings of dairy per day?
Do you exercise less than 4 times a week for less than 30 minutes?
Do you smoke cigarettes or drink alcohol in excess?
Do you have a history of osteoporosis in you 6mily?
Do you have a history of hip, wrist or spinal fractures in your âmily?
Do you have or have you had an eating disorder?

0 Yes
□ Yes
□ Yes
□ Yes
□ Yes
□ Yes
□ Yes
□ Yes
□ Yes

□ No
□ No
□ No
□ No
□ No
□ No
□ No
□ No
□ No

The more times you answer “yes” the greater your risk for developing osteoporosis.
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APPENDIX B

Informed Consent Form
The purpose of diis study is to assess if a person's awareness of measures to prevent osteoporosis
is related to her bone health. The infonnaticm that is collected from this investigation may help
to furdrer the awareness of osteoporosis prevention and increase the use of preventive measures
by womm to ensure good bone health.
Particqmtion in this study will include responding to questions asked while having die
screening bone density measurement perfrmned and will take approximate^ five mimnaa to
conylete. These questions will include information on measures necessary to prevent
osteoporosis.
No expected risks, discomfrnts, or benefits are expected widi this study. Your decision to take
part in this research study is entirely voluntary and you may withdraw at any time.
All data collected will remain confidential. Only the researcher and her faculty supervisor will
have access to die files. Your name will not be associated with the study in any way.
Ary questions may be addressed to Kathy A . Schneider, 12552 LeVau Court #106, Fairfax, VA
22033, phone number (703)322-9004. Questions may also be addressed to C. Gene Bums.
Ph.D.. Department of Healdi and Human Performance Chair. McGill Hall, University of
Montana, Missoula, MT 59812, phone number (406)243-5241.
Although we do not frnesee any risk in taking part in this study, the following liability statement
is required in all University of Montana consent forms:
"In the event diat you are injured as a result o f this research you should individually seek
tqipcopnate medkûü treatment If die injury is caused by the negligence of the Universi^ or any
of its enqilqyees, you may be entitled to reimbursement or cmnpensation pursuant to the
Conqnehoisive State Insurance Plan established by the Departmoit of Administration under the
authority of M C A ., Title2, Chapter 9. In die evrot of a claim for injury, further information
may be obtained from the University's Claims representative of University Legal Counsel."
I have read the above description of this research study. I have been informed that there are no
expected risks or benefits involved, and all nay questimis have been answered to my satisfoction.
Furthermore, I have been assured that any future questions that I may have will also be answered
by a member of the research team. I voluntarily agree to take part in diis study and give
permission to the researcher to obtain my bone density screening measurement. I understand I
will receive a copy o f this consent form.
Printed name of subject
Subject's s%uature
Date
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APPENDIX C

Bone Density Testing Consent Form
I undeistand that I have elected to have the DEXA bone density test to be performed at my request:

The screening is a noDHnvasive procédure that uses the portable pDEXA or Apollo instrumentatian
■ The procedure will require me to be seated, but remain still. I should not experience any discomfort
■ I am required to place nty non-dominant atm on the surihoe of the pDEXA or mthe case of Ae
Apollo, place my nm-daminant heel in the mouth of the DEXA instrumenL
■ I understand that the DBCA instiumeats use a very low dosage of X-Ray with an exposure sigoifi
cantly less than a standard chest X-Ray (équivalent to l/20th of diat dosage received). The X-Ray
win pass thrtx^b my fbreann on the pDEXA or through my heel on the Apollo.
■ I understand that the X-Ray exposure may be hattnfiil to a developing baby. If I am or may be
pregnant, I roust inAnn the technologist and not pardcqtate.
■ I understand the DEXA instrumeots being used for this screening are qxproved by the FDA for
general clinical use.
■ I understand that the results of the above screeniog procedure will be made available to roe immedi
attdy to consult with my physician. ?4o medical advice wiB be dispensed to meat any time by the
screming tedmidans.
■ I understand that paiticipaticn in this screening procedure will not prevent me fiom bavir% os
teoporosis.
■ I understand I am reqwnstble for any fbUow-up examinations with irtyphysician.
Please answer "True” or "False” to the following questions:

lamfisnale?
IdQdiaEv<esmokedtobacco?Past?

1am Caucasian or Asian?

____ lamoveragedS?

____I do/have drankalcohol? Past?

I have a 6mily history of osteoporosis?

I do not take calcium?

Ihaverheumatoidarthritis?

_I do not exercise on a regular basis?

I do not eat healthy on a regular basis?

_I have had an eatiog disorder in the past?

IdBjOOl consume] +dairyser\Tngsperday?

I have/do taire one or more of the following methcations: Steroids, Prednisone, Cortisone, Thyroid,
ami-convulsants, hormones, or any of the tqiproved osteoporosis medications)?
I understand that I must answer “TRUE” to three or more of the osteoporosis RISK âctors listed ate vs
in order to have a bone density test today. I have read, understood and accept the above statements.
Signature___________________________ ;________________________ Date______________
Please Print Name

Date of birth_

Are you right handed?
What ethnic origin are you?___________________
_Are you left handed?________ Height_______________ Weighty
Do you fiuquently visit this screening site for other reasons?

YES
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a p p e n d ix d

1. What is your age? .,

2. i How long has it been since your last ; «v*; :

' ' • t f i y ’r :

3l Have you beiim-diagnosed'-'wrtrtiji^;r^''^-''i^ .(4 '
i^.osteopon»sls?^§^^li:^:;;f^-

Is. ; In which range does the racommended daily
' calcium intake for postmenopausal women
r v : ^ : f a ll? : '; ^ \ V

,T ^ -

; : • ,■ ■ •

■

:Xl' C. ' 1201-1500mg •- '-v'"
f; O. 1501-2000 mg

^

E. idoniknow

^

" ï ' O . Jt , -*—

' • S“ î '

‘ s I # ’, * fi‘ '

f

S 4 % t % m B l e o , V ^ '^ . W l o w ^ ' '* r o o e « h ^

ï>^^v>have undep^nevrtthin the -last"*lvaÿdays:'^%' :

S. %ln: order to Increase calcium absorption, S ts ;

I

<>Take aVof the recommend^ calciuman one ]

; 4?' B:% Divide doses ofcalcium and take throughout
==^-'l ■v '
■> '.V
rf...

7. '.The current recommended daily intake of
Vitamin D Is: '
; A: 100-400lU ^
B. 401-800 lU
, C. 601-1000 iU
D. I doni know
; ;
■

What is tire function of Vitamin O In thé^
..-prevendon of osteoporosis? ^
f - V At>; ;ttjncreases the absorptionlof wfâÜrhf^
B; It increases the rate at which bone if formed
: . C, it decreases the rate at which bone is broken |

9. What Is the most effective measure for tire
prerrention of osteoporosis In
: postmerropausal worrten?
A. Calcium intake
.\
B. Estrogen replacement therapy
0. i doni know
<

'Id. '

A.
B.
C.
D.

Which exercise Is least likely to help
maintain bone mass?
Walking
;
Srwmmirrg :
. ^
Weight Bfting
I dont know
.k.'f::);

A.
0.

Wtrat is your priirrary source o f .
;
information on osteoporosis?
Family member /friend B. The media
Your physician
D. Your pharmacist

13.

B:-

' - 'l:y/ -.down-/.:y:%:\,

D: " i donlftnow

\ ;; A

Postmenopausal estrogen replaeemeirt
then^y has troth beirefits and hazards
associated with IL ;
'
True
- :

Bj:y.Fabe

: . C.

Idont know

v

T: '
J

. Exercise Is heipftil in the prevention of
. - osteoporosis because:
".
Â ft promotes weight loss
B; Itincreases muscle strength ' _
C. it helps to strengthen bone ^
D., Idont know. V-.
. .
.

' Are you confident of your icnowMge
of the e t ^ s to take to prevent ï ’û lï
osteoporosis?
A. Yes
B. No
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APPENDIX E

ID

Etzhnjj:
JIalghc

3809
Sex

Wez she

Female

L Forearm on 0 6 / 3 0 / 9 9

14:41
projc. R-rlJ Caucaa
N o r l a n d 793

D i s c . R+U C a u c a s i a n

N o r l a n d 798

0. 457

Caucasian

Low R i s k

ia-w Ri.,k

M Medium R is k
D

Medium S i s k

AGE

06/30/99

* You n g R e f .
I - Score

Bone i m a g e n o t

44. 0

58.7

Score

-2.32

-

06/30/99

* Young R e f .

-3.91

Z Ag e Maccheti
Z

AGE

95

0.154

T - Score
S Ag e M a t c h e d
Z - Score

for d ia g n o sis

D i s t . R+U

BMD
g/cm^
0.154

BMC
S
0,722

LENGTH
cm
1.00

Prox.
Prox.

0.468
0 . 463

1.077
0.573

1.00
1 .00

R+U
R

STD CV f o r D i s t a l R+U BMD:
1 . 0 X 1 . 0 ram,

24 mm/s,

6.00

cm

1.4
Rev.

See Guide

f o r o c h e r CVs .

3.3.0/1.1.1

Caiib.

06/29/99

COMMENTS

iM ND RLflNa
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0.463

57.2
-5.57
76.8
- I . 42
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